Northwest Biotherapeutics Inc.
NWBO
OTCQB
Sector: Healthcare
Industry: Biotechnology
0.91
USD
-0.05
(-4.71%)
Optionable: No Market Cap: 922 M 90-day average vol: 1,485,112
Previous close: 0.9601 Open: 0.9599 Bid: Ask:
52 week range
0.59 2.15
Last updated: Thursday 14th April 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 1,213.64 |
Price per Book TTM ($) | -7.04 |
PE Ratio (TTM) | -20.90 |
Book Value per Share ($) | -0.13 |
5 Year PE Range | -5.3 , -0.5 |
Returns
Risk
Custom Beta One Year | 0.00 |
Custom Beta Three Years | 0.00 |
Beneish M Score | 0.00 |
Altman Z Score | -122.81 |
Dividends
Financial Health
Technicals
RSI (14 Day) | 66.79 |
14 Day SMA ($) | 0.77 |
14 Day EMA ($) | 0.81 |
Money Flow Index | 58.09 |
Average True Range | 0.06 |
50 Day SMA ($) | 0.82 |
200 Day SMA ($) | 1.02 |
ADX | 8.36 |
MACD | 0.03 |
Growth
Free Cash Flow QoQ Growth | 16.93% |
Free Cash Flow YoY Growth | 20.12% |
Revenue YoY Growth | -46.43% |
EPS QoQ Growth | 400.00% |
Revenue QoQ Growth | -15.87% |
EPS YoY Growth | 1725.00% |
Profitability
Chart
News
Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
Yahoo Finance 2/17/2022
Northwest Biotherapeutics Announces MHRA Approval Of License for GMP Manufacturing At Sawston, UK Facility
Yahoo Finance 12/21/2021
Northwest Biotherapeutics: No TLD Yet
Seeking Alpha 12/19/2021
Northwest Biotherapeutics secures $15M financing on stock purchase rights
Seeking Alpha 11/29/2021
Northwest Biotherapeutics Announces $15 Million Financing
Yahoo Finance 11/29/2021
Northwest Biotherapeutics Announces HTA License Issued and MHRA Inspection Conducted for Sawston, UK Facility
Yahoo Finance 10/28/2021
Northwest Bio: Nowhere To Go But Up
Seeking Alpha 10/13/2021
Northwest Biotherapeutics: CEO Says Unblinding Is A Work In Progress
Seeking Alpha 5/24/2021
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Financials
NWBO Income Statement
Annual
| Dec-12 | Dec-13 | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 772000 | 809000 | 1 M | 2 M | 623000 | 336000 | 412000 | 2 M | 1 M | 1 M |
| Cost of sales | -14000 | -11000 | -11000 | -56000 | -189000 | -439000 | -1 M | 301000 | -425000 | -586000 |
| Gross operating profit | 772000 | 809000 | 1 M | 2 M | 623000 | 336000 | 412000 | 2 M | 1 M | 1 M |
| Selling Gen & administrative expense | 16 M | 12 M | 17 M | 25 M | 20 M | 21 M | 27 M | 16 M | 54 M | 33 M |
| Research & development expense | 29 M | 44 M | 86 M | 103 M | 60 M | 34 M | 18 M | 14 M | 34 M | 20 M |
| Operating income | -44 M | -55 M | -101 M | -126 M | -79 M | -55 M | -45 M | -28 M | -87 M | -53 M |
| floaterest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| floaterest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income net | -10 M | -9 M | -33 M | 16 M | 3 M | -13 M | 19 M | 10 M | -435 M | 237 M |
| Pre-tax Income (EBT) | -67 M | -66 M | -136 M | -115 M | -80 M | -73 M | -36 M | -21 M | -530 M | 179 M |
| Income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from total operations | -67 M | -66 M | -136 M | -115 M | -80 M | -73 M | -36 M | -21 M | -530 M | 179 M |
| Minority floaterest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total net income | -67 M | -66 M | -136 M | -115 M | -80 M | -73 M | -36 M | -21 M | -530 M | 179 M |
| Preferred dividends | N/A | N/A | N/A | N/A | 6 M | 1 M | 18 M | N/A | N/A | N/A |
| Net income available for common | -67 M | -66 M | -136 M | -115 M | -86 M | -74 M | -54 M | -21 M | -530 M | 179 M |
| Depreciation | 14000 | 11000 | 11000 | 56000 | 189000 | 439000 | 1 M | -301000 | 425000 | 586000 |
| Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income before depreciation (EBITDA) | -54 M | -65 M | -135 M | -111 M | -76 M | -67 M | -25 M | -18 M | -521 M | 185 M |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic EPS total | -5.72 | -2 | -2.29 | -1.48 | -0.77 | -0.31 | -0.12 | -0.04 | -0.73 | 0.21 |
| Diluted EPS total | -5.72 | -2 | -2.29 | -1.48 | -0.77 | -0.31 | -0.12 | -0.04 | -0.73 | -0.06 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!